PA
JBSS icon

PharVision Advisers’s John B. Sanfilippo & Son JBSS Stock Holding History

PharVision Advisers’s Portfolio JBSS Stock Details JBSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,223
Closed -$228K – 381
2025
Q4 		$228K Buy
3,223
+6
+0.2% +$408 0.12% 455
2025
Q3 		$207K Buy
+3,217
New +$208K 0.12% 489

Other funds holding JBSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

PharVision Advisers's JBSS Position: Q1 2026 in Review

PharVision Advisers sold out of John B. Sanfilippo & Son (JBSS) in Q1 2026, closing a stake of 3,223 shares — an estimated $228K sold.

PharVision Advisers first reported a position in JBSS in Q3 2025 and held it in 2 quarters. The position peaked at $228K in Q4 2025. 214 funds tracked by Wall St. Rank hold JBSS as of Q1 2026.

  • PharVision Advisers reported no remaining John B. Sanfilippo & Son position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 3,223 John B. Sanfilippo & Son shares in Q1 2026, an estimated $228K.
  • PharVision Advisers first reported a position in John B. Sanfilippo & Son in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's John B. Sanfilippo & Son position peaked at $228K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held John B. Sanfilippo & Son as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.